Hythiam, Inc. (NASDAQ:HYTM) today announced that Chairman and Chief Executive Officer, Terren Peizer, will be presenting at the Noble Financial Two Double-0-Seven Small Cap Equity Conference, which will be held August 20-21 at the Charleston Place Hotel in Charleston, South Carolina. The presentation will be webcast live on August 21st at 8:00 AM ET, and archived for future reference on Hythiam’s website, www.hythiam.com, as well as Noble Financial’s conference website, www.two-007.net. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.
Conference Information: www.two-007.net
Noble Financial Website: www.nobleresearch.com
About Hythiam, Inc.
Hythiam, Inc. provides behavioral health management services to health plans, employers, criminal justice, and government agencies through a network of licensed and company managed providers. The company approaches the management of behavioral health disorders with a focus on using the latest medical and health technology towards improved outcomes and out-patient treatment. Hythiam also researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment programs. Hythiam offers disease management for substance dependence built around its proprietary PROMETA® Treatment Programs for alcoholism and dependence to stimulants. The PROMETA® Treatment Programs, which integrate behavioral, nutritional, and medical components, are available through both licensed treatment providers and company managed PROMETA Centers. Hythiam does not practice medicine nor manufacture, distribute, or sell any medications and has no relationship with any manufacturers or distributors of medications used in the PROMETA® Treatment Programs. For further information, please visit www.hythiam.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history and lack of statistically significant formal research studies, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the healthcare industry; and additional risks factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at http://www.sec.gov.